Systematic Financial Management LP Acquires Shares of 16,065 Teleflex Incorporated $TFX

Systematic Financial Management LP acquired a new stake in Teleflex Incorporated (NYSE:TFX) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 16,065 shares of the medical technology company’s stock, valued at approximately $1,922,000.

Other hedge funds have also recently modified their holdings of the company. Ruffer LLP acquired a new stake in shares of Teleflex during the 4th quarter worth approximately $5,154,000. Waterfront Wealth Inc. purchased a new position in shares of Teleflex during the 4th quarter valued at approximately $2,050,000. Eos Management L.P. acquired a new position in shares of Teleflex in the 4th quarter valued at $3,763,000. Universal Beteiligungs und Servicegesellschaft mbH lifted its stake in shares of Teleflex by 227.5% in the 4th quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 27,822 shares of the medical technology company’s stock valued at $3,395,000 after purchasing an additional 19,327 shares during the period. Finally, First Eagle Investment Management LLC boosted its holdings in Teleflex by 163.4% during the fourth quarter. First Eagle Investment Management LLC now owns 84,300 shares of the medical technology company’s stock worth $10,288,000 after buying an additional 52,300 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Teleflex stock opened at $131.86 on Friday. The company’s fifty day moving average price is $130.85 and its 200 day moving average price is $120.88. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $139.67. The stock has a market capitalization of $5.84 billion, a P/E ratio of -5.78, a P/E/G ratio of 0.97 and a beta of 0.82. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping the consensus estimate of $1.21 by $0.18. The company had revenue of $548.30 million during the quarter, compared to analyst estimates of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm’s revenue was up 32.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts anticipate that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th were given a $0.34 dividend. The ex-dividend date was Friday, May 22nd. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is -5.96%.

Analysts Set New Price Targets

Several analysts recently commented on TFX shares. Bank of America upgraded shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target on the stock in a research report on Monday, April 13th. Truist Financial reiterated a “hold” rating and issued a $143.00 price objective (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. Wall Street Zen raised shares of Teleflex from a “sell” rating to a “hold” rating in a research note on Saturday, June 27th. Raymond James Financial restated an “outperform” rating and set a $150.00 target price on shares of Teleflex in a research report on Friday, May 8th. Finally, Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $140.00 to $160.00 in a research note on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $148.00.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.